Empty Capsules Market Future Outlook

calendar_today 21 March, 2023 person_outline Growth Plus Reports


Empty capsules are soluble casings or containers that hold medications. Often, these capsules are used to preserve herbs, powders, and medications. They come in sizes ranging from 000 (biggest) to size 5. (smallest). The capsules are also available in a variety of colors and tastes. Gelling agents such as animal protein, plant polysaccharides, or their derivatives make empty capsules. Gelatin empty capsules are derived from animal ingredients like collagen and are best suited for powdered compositions. Non-gelatin empty capsules are constructed from plant materials or derivatives such as cellulose. They are often used in semi-solid and gel formulations.

The two basic types of empty capsules are gelatin capsules and non-gelatin capsules. Non-gelatin capsules provide a number of advantages, including increased resilience to humidity and heat. Non-gelatin capsules are becoming more popular as the demand for non-animal-based products is increasing.

Who are the Top 5 Companies in the Empty Capsules Market?

Thermo Fisher Scientific Inc, ACG, Catalent, Inc., Qualicaps, and CapsCanada are the top 5 companies in the empty capsules market.

Recent Developments in the Empty Capsules Market

  • CapsCanada, a Lyfe Group company, announced the launch of a new liquid-filled hard capsule manufacturing service in March 2021.
  • Catalent, Inc. launched OptiGel DR, a novel delayed-release soft gel technology, in October 2020. This technology eliminates the need for a separate capsule-coating procedure by mixing pectin and gelatin to make soft gel capsules.
  • Dr. Reddy Laboratories obtained US Food and Drug Administration (USFDA) clearance in August 2020 to launch generic Penicillamine capsules in the US market to treat Wilson's disease and cystinuria.

What lies ahead for the global Empty Capsules Market?

The market for empty capsules is expected to surpass $58.30 billion by 2030, growing at a 6.0% CAGR, indicating a promising future for the industry. The increasing elderly population with an increasing demand for medications, increasing R&D efforts in the pharmaceutical sector, and innovations in capsule drug delivery methods will drive revenue growth in the empty capsules market. Nevertheless, ethical issues, a lack of raw materials (particularly gelatin), and rigorous regulations in the pharmaceutical sector are some of the challenges that are expected to hamper market revenue growth to some extent.